|8.14||-0.18 / -2.16%|
Data as of 3:59pm ET
|8.14||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 14.00 and a low estimate of 8.00. The median estimate represents a +47.42% increase from the last price of 8.14.
The current consensus among 3 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.